0001437749-24-019350.txt : 20240605
0001437749-24-019350.hdr.sgml : 20240605
20240605171212
ACCESSION NUMBER: 0001437749-24-019350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240605
DATE AS OF CHANGE: 20240605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TATE JEFFREY
CENTRAL INDEX KEY: 0001499075
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39780
FILM NUMBER: 241022951
MAIL ADDRESS:
STREET 1: C/O CTD HOLDINGS, INC.
STREET 2: 27317 NW 78TH AVENUE
CITY: HIGH SPRINGS
STATE: FL
ZIP: 32643
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc.
CENTRAL INDEX KEY: 0000922247
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 593029743
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6714 NW 16TH STREET, SUITE B
CITY: GAINESVILLE
STATE: FL
ZIP: 32653
BUSINESS PHONE: 386-418-8060
MAIL ADDRESS:
STREET 1: PO BOX 1180
CITY: ALACHUA
STATE: FL
ZIP: 32616-1180
FORMER COMPANY:
FORMER CONFORMED NAME: CTD HOLDINGS INC
DATE OF NAME CHANGE: 20000913
FORMER COMPANY:
FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC
DATE OF NAME CHANGE: 19941012
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-06-03
0000922247
Cyclo Therapeutics, Inc.
CYTH
0001499075
TATE JEFFREY
C/O CYCLO THERAPEUTICS, INC.
6714 NW 16TH STREET, SUITE B
GAINESVILLE
FL
32163
1
1
Chief Operating Officer
0
Stock Option (Right to Buy)
1.28
2024-06-03
4
A
0
110732
0
A
2034-06-03
Common Stock
110732
110732
D
The option vests over a one year period in equal quarterly installments.
/s/ Jeffrey Tate
2024-06-05